Evidence overview
Caffeine
Caffeine is one of the most-researched ergogenic aids in modern supplement science, with an unusually replicated literature on exercise performance and a substantial secondary base on cognitive function, mood, headache, and metabolic effects. Most adult consumers reach effective doses through coffee, tea, and energy drinks, which makes the supplement-vs-dietary distinction less meaningful than for most other substances. Genetic variation in metabolism is one of the most-personalizable response modifiers in supplement science.
Most studied for
Coverage pending
PubMed coverage
Coverage pending
Safety profile
In your full report
Mechanism class
Adenosine receptor antagonist (primarily A1 and A2A subtypes); blocks adenosine's inhibitory effects on the...
Study coverage
Study coverage by goal
PubMed counts for Caffeine grouped by the goal each study targets.
Evidence overview is temporarily unavailable for Caffeine.
Evidence
What the evidence covers
The terrain of the published literature, not its conclusions.
Caffeine is one of the most-researched substances in modern supplement science, with a literature spanning endurance exercise performance, muscle strength and power output, cognitive function (especially alertness and reaction time), mood and well-being, headache treatment (as an active ingredient in many over-the-counter analgesics), and metabolic effects. It works through adenosine receptor antagonism, blocking the dampening effect of adenosine on the central nervous system. Most caffeine research has been conducted on doses commonly delivered by coffee, tea, energy drinks, and pre-workout supplements (roughly 1-6 mg/kg body weight), which makes 'supplemental' caffeine and 'dietary' caffeine less methodologically distinct than for most other substances.
The outcome dimensions covered most heavily are endurance exercise performance (the most-studied indication, with trials across many designs and athletic populations), muscle strength and power output, cognitive function and alertness (especially under sleep deprivation or mental fatigue), mood, headache treatment, and weight management (smaller and more contested literature). Newer research streams include effects on perceived exertion specifically, sport-specific performance metrics in team sports, and habitual-vs-acute caffeine effects in chronic users.
Demographically, the literature concentrates heavily on young trained athletes (the dominant performance-research population), with substantial healthy-adult cognitive subsamples and growing older-adult literature. Genetic variation in caffeine metabolism (via CYP1A2 polymorphisms) is an actively expanding research area: fast and slow metabolizers respond differently to the same dose, which is one of the most-personalizable variables in supplement science. Timing of administration (typically 30-60 minutes before exercise for performance use) and habituation status both meaningfully modify response.
Safety
Safety summary
Common adverse events, drug interactions, and special populations.
Caffeine is well-tolerated at moderate doses and is recognized as generally safe by regulatory bodies. The European Food Safety Authority recommends limiting habitual intake to roughly 400 mg/day for adults and lower for pregnant women (around 200 mg/day). Common adverse effects at higher doses include jitteriness, insomnia, increased heart rate, anxiety, and gastrointestinal discomfort. Acute caffeine toxicity is rare but possible at very high single doses (typically over 1,000 mg in caffeine-naive individuals), and several deaths have been reported from concentrated caffeine-powder supplements. Drug interactions include additive effects with stimulants and some antidepressants, reduced clearance with certain antibiotics (ciprofloxacin), and slowed metabolism in users of hormonal contraceptives. People with cardiac arrhythmias, anxiety disorders, or in pregnancy should consult a clinician about appropriate intake.
This summary is informational and not medical advice. Consult a clinician before starting or changing any supplement, especially if you take prescription medications.
Foundations
Foundation of the evidence base
A few studies the field anchors on. Not the full picture, just the starting points.
Umbrella review synthesizing 21 separate meta-analyses on caffeine and exercise performance, published in a leading sports medicine journal. The single most-comprehensive supplement-overall reference for caffeine's primary established use.
View on PubMedWidely-cited meta-analysis quantifying caffeine's ergogenic effect specifically on endurance performance - the supplement's most-studied indication and the one that anchors the broader ergogenic claim.
View on PubMedMeta-analysis published in the ISSN's own journal, addressing the second-most-studied performance application (strength and power output). Establishes the field reference for ergogenic effects beyond endurance.
View on PubMed
Limitations
What this page doesn't answer
Where the public summary stops and the personalized report begins.
This page summarizes the caffeine literature at a general level. It does not address what dose is right for your specific goal (most consumer products are far from optimized to evidence-based ranges), how your individual metabolic profile (fast vs. slow CYP1A2 metabolizer) affects your response, timing considerations for your context, or how caffeine interacts with the medications and supplements you take. Genetic variation in caffeine response is one of the most-personalizable variables in supplement science, which makes this an area where the personalized report can be especially valuable.
Personalized to you
Get a personalized Caffeine report
Your free first report adds the things this page doesn't: per-goal evidence breakdown, demographic-specific findings, full citation list, and a safety section tailored to your profile.
Free first report. No credit card. Cancel anytime.
Get notified when new evidence appears
We'll email you when the literature on Caffeine materially updates. No account required.